Quantitative evaluation of liver cirrhosis using T1 relaxation time with 3 tesla MRI before and after oxygen inhalation

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 2, 2012, Pages 405-410

  Kim, Kyung Ah ^a   Park, Mi Suk ^a   Kim, In Seong ^b   Kiefer, Berthold ^c   Chung, Woo Suk ^a   Kim, Myeong Jin ^a   Kim, Ki Whang ^a  

^a Yonsei University   (South Korea)

^b Siemens Healthcare   (South Korea)

^c MR Applications Development   (Germany)

Author keywords

liver cirrhosis; magnetic resonance imaging; oxygenation; T1 relaxation time

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN BREATHING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELAXATION TIME;

ADMINISTRATION, INHALATION; ADULT; AGED; CONTRAST MEDIA; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN;

EID: 84864249183     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23620     Document Type: Article

References (27)

1. Desmet VJ, Roskams T,. Cirrhosis reversal: a duel between dogma and myth. J Hepatol 2004; 40: 860-867. (Pubitemid 38507370)
2. Bortolotti F, Guido M,. Reversal of liver cirrhosis: a desirable clinical outcome and its pathogenic background. J Pediatr Gastroenterol Nutr 2007; 44: 401-406. (Pubitemid 46573220)
3. Friedman SL,. Liver fibrosis-from bench to bedside. J Hepatol 2003; 38: 38-53.
4. Borra RJ, Salo S, Dean K, et al. Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging. Radiology 2009; 250: 130-136.
5. Wang HZ, Riederer SJ, Lee JN,. Optimizing the precision in T1 relaxation estimation using limited flip angles. Magn Reson Med 1987; 5: 399-416. (Pubitemid 17167630)
6. Taouli B, Ehman RL, Reeder SB,. Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol 2009; 193: 14-27.
7. Bonekamp S, Kamel I, Solga S, Clark J,. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol 2009; 50: 17-35.
8. Chamuleau RA, Creyghton JH, De Nie I, Moerland MA, Van der Lende OR, Smidt J,. Is the magnetic resonance imaging proton spin-lattice relaxation time a reliable noninvasive parameter of developing liver fibrosis? Hepatology 1988; 8: 217-221.
9. Kreft B, Dombrowski F, Block W, Bachmann R, Pfeifer U, Schild H,. Evaluation of different models of experimentally induced liver cirrhosis for MRI research with correlation to histopathologic findings. Invest Radiol 1999; 34: 360-366. (Pubitemid 29198346)
10. Goldberg HI, Moss AA, Stark DD, McKerrow J, Engelstad B, Brito A,. Hepatic cirrhosis: magnetic resonance imaging. Radiology 1984; 153: 737-739. (Pubitemid 15190051)
11. Thomsen C, Christoffersen P, Henriksen O, Juhl E,. Prolonged T1 in patients with liver cirrhosis: an in vivo MRI study. Magn Reson Imaging 1990; 8: 599-604. (Pubitemid 20321976)
12. Thomsen C,. Quantitative magnetic resonance methods for in vivo investigation of the human liver and spleen. Technical aspects and preliminary clinical results. Acta Radiol Suppl 1996; 401: 1-34.
13. Tadamura E, Hatabu H, Li W, Prasad PV, Edelman RR,. Effect of oxygen inhalation on relaxation times in various tissues. J Magn Reson Imaging 1997; 7: 220-225. (Pubitemid 28365664)
14. O'Connor JP, Jackson A, Buonaccorsi GA, et al. Organ-specific effects of oxygen and carbogen gas inhalation on tissue longitudinal relaxation times. Magn Reson Med 2007; 58: 490-496. (Pubitemid 350154959)
15. Jones RA, Ries M, Moonen CT, Grenier N,. Imaging the changes in renal T1 induced by the inhalation of pure oxygen: a feasibility study. Magn Reson Med 2002; 47: 728-735. (Pubitemid 34263786)
16. Noseworthy MD, Kim JK, Stainsby JA, Stanisz GJ, Wright GA,. Tracking oxygen effects on MR signal in blood and skeletal muscle during hyperoxia exposure. J Magn Reson Imaging 1999; 9: 814-820. (Pubitemid 29266394)
17. Deoni SC, Rutt BK, Peters TM,. Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state. Magn Reson Med 2003; 49: 515-526. (Pubitemid 36262820)
18. de Bazelaire CMJ, Duhamel GD, Rofsky NM, Alsop DC,. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004; 230: 652-659. (Pubitemid 38252858)
19. Ito K, Mitchell DG, Gabata T, et al. Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging. Radiology 1999; 212: 235-240. (Pubitemid 29302541)
20. Krinsky GA, Lee VS, Nguyen MT, et al. Siderotic nodules in the cirrhotic liver at MR imaging with explant correlation: no increased frequency of dysplastic nodules and hepatocellular carcinoma. Radiology 2001; 218: 47-53. (Pubitemid 32151271)
21. Rodriguez-Moreno F, Gonzalez-Reimers E, Santolaria-Fernandez F, et al. Zinc, copper, manganese, and iron in chronic alcoholic liver disease. Alcohol 1997; 14: 39-44. (Pubitemid 27052108)
22. Bataller R, Brenner DA,. Liver fibrosis. J Clin Invest 2005; 115: 209-218. (Pubitemid 40385459)
23. Materne R, Annet L, Dechambre S, et al. Dynamic computed tomography with low- and high-molecular-mass contrast agents to assess microvascular permeability modifications in a model of liver fibrosis. Clin Sci (Lond) 2002; 103: 213-216.
24. Chen ML, Zeng QY, Huo JW, Yin XM, Li BP, Liu JX,. Assessment of the hepatic microvascular changes in liver cirrhosis by perfusion computed tomography. World J Gastroenterol 2009; 15: 3532-3537.
25. Eipel C, Abshagen K, Vollmar B,. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol 2010; 16: 6046-6057.
26. Kleber G, Steudel N, Behrmann C, et al. Hepatic arterial flow volume and reserve in patients with cirrhosis: use of intra-arterial Doppler and adenosine infusion. Gastroenterology 1999; 116: 906-914. (Pubitemid 29153539)
27. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE,. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003; 229: 409-414. (Pubitemid 37310826)